TrabTech, the spin-off company of BTech (now Addpark), which develops products and services in the field of additive manufacturing, received an investment of $6 million.
TrabTech, the spin-off company of BTech (currently Addpark), which was founded in 2013 at ODTU TEKNOKENT and develops products and services in the field of additive manufacturing, received an investment of $6 million. The tour was attended by Fark Holding, Teknokent Venture Support and Investment, Coskunoz Holding, Ahu Serter, Sule Mene, Emin Atac, Omer Burhanoglu, Deniz Buyukkusoglu, Mehmet Murat Ayabakan and Ertugrul Birol Sen.
In addition to this investment, TrabTech received €1.3 million from European Union funds for new implant materials to be developed in orthopedics and pediatrics, including advanced material research and pediatric applications.
With these supports, TrabTech aims to commercialize the hip prosthesis TrabCup, the first mass-produced product, to complete the regulation processes of newly developed products, to open the European Market by moving the company headquarters to Germany, and to continue the FDA application preparations. Among the founders of TrabTech are Kuntay Aktas, the founder of the Katalist Investment company, Dr. Erol Teberoglu, and the partners of BTech.
TrabTech is developing the “Trabecular Implant” series, which is a new manufacturing method and can be used in young and old patients, which can integrate with the bone much faster, provide rapid healing, and can be used in young and old patients, with the additive manufacturing method, also known as 3D printers. The surface technology, which is similar to the trabecular structure of the bone on the implant surface, allows the growth of bone and tissues, while keeping the tissue and blood supply at the maximum level thanks to its hollow structure, and the nano-level roughness creates a special environment for the cells to adhere. Moreover, implants produced with titanium material and additive manufacturing provide flexibility and easy stabilization as well as high biocompatibility, strength and friction coefficient. In this way, it is aimed to increase the life of the implants in the human body and to significantly increase the quality of life of patients who are elderly or have had implant surgery before.
Having worked for many years in this technology, which has triggered a great transformation with the innovations it has brought in the implant industry, the TrabTech team has taken an important step by certifying the hip implant project, which is the first mass-produced product in Turkiye as a Class III medical device, and one of the few examples in the world, together with personalized implants. The product is planned to be on the market in 2023.
Porous structures called lattice structures in Additive Manufacturing are known as a complicated design method that requires advanced use of “Design with Additive Manufacturing” methods. TrabTech, which has been doing research in this field for many years and has an experienced team in product development, uses its knowledge both in the medical products on the market and in new R&D projects it carries out to develop high-tech new implant systems.
Kuntay Aktas, CEO of the company, referring to the collaborations of TrabTech, said, “When we started working in this field, “Additive Manufacturing” technology and medical uses were not very common and well-known. At the point we have reached today, we can talk about the acceptance of a technology that will transform the implant industry. Such transformations can only happen with good cooperation. We implement the products we develop in cooperation with the world’s most prestigious universities and institutions. TrabTech is not an implant or orthopedic firm. It is a new-generation technology company with its methods, tools, way of doing business and multinational corporate culture beyond the products it develops. We are even more excited as our vision and competency are recognized by our joint work with important institutions in Switzerland, Germany, Sweden, England and America. Our aim is to be one of the most important technology companies in the world that develops high-quality products in this field. I would like to thank our investors who believed in us, our hardworking, well-equipped and passionate engineering team who made this dream come true, the scientists we work with, and our industrial friends who contributed to the development of “Additive Manufacturing” and “Medical 3D Printing” applications.”
Another important development of TrabTech, which was established in Turkiye and whose European office continues to be established these days, is new research projects that will start in 2023. A new project led by TrabTech, which is involved in many research groups with the most respected and important universities and institutions in Europe with its expertise in “Additive Manufacturing” technology, known as 3D printers in the medical field, received approval from the European Commission in the past months.
It is also aimed to develop implant products in which various artificial intelligence-supported design methods and special hollow structures will be used with a new process. The project, which will be supported by scientists from Hungary, creates an important research resource with a budget of €1.3 million.
Source: Egirisim / Translated by Irem Yildiz